Cochlear's annual general meeting insights

Cochlear (ASX:COH) held its 2024 Annual General Meeting on October 25, 2024. The meeting showcased the company's dedication to innovation and expanding access to hearing solutions. Key highlights included record sales revenue, new product launches, and strategic growth opportunities.

Cochlear's strategic milestones and future outlook

Cochlear's 2024 AGM emphasized its mission to connect people through hearing solutions. The company reported record sales revenue of $2.3 billion and a strong net profit increase. New products like the Cochlear Osia OS1300 Implant and advancements in research highlight its commitment to innovation. The expansion of funding and market access, along with a focus on cognitive health and environmental responsibility, position Cochlear for sustained growth. With a robust balance sheet and strategic initiatives, Cochlear is well-equipped for future success, aiming for a 6-11% net profit increase in FY25.

Executive insights on Cochlear's performance

Our mission-driven culture and dedication to innovation set us apart. We are committed to helping people hear and be heard, and our recent achievements, including record sales and expanded market access, are a testament to our team's hard work and vision.